Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis — Stella

Home/Metastatic Melanoma/

View on ClinicalTrials.gov

Recruiting

Back to Metastatic Melanoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

UW Hospital and Clinics, Madison, Wisconsin

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Wisconsin, Madison

Collaborators

Delcath Systems Inc.

Enrollment target

~15 participants

Started

April 2026

Primary completion

December 2030

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Last updated March 2026